Skip to main content
Clinical Trials/NL-OMON26522
NL-OMON26522
Recruiting
Not Applicable

Midtrimester preterm prelabour rupture of membranes (PPROM). Expectant management or Amnioninfusion for improving perinatal outcomes.

Academical Medical Centre Amsterdam0 sites56 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Perinatal mortality. The number of stillbirths and deaths in the first week of life.Perinatale sterfte. Het aantal doodgeborenen en doden in de eerste levensweek.Keywords: Midtrimester preterm prelabour rupture ofmembranes. Perinatal outcome. Oligohydramnios. Amnioinfusion.
Sponsor
Academical Medical Centre Amsterdam
Enrollment
56
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Academical Medical Centre Amsterdam

Eligibility Criteria

Inclusion Criteria

  • Women with a singleton pregnancy complicated by oligohydramnios secondary to PPROM at a gestational age between 16 and 24 weeks, minimum 72 hours after PPROM was diagnosed, but no longer than 21 days after this diagnosis.

Exclusion Criteria

  • Women having signs of premature uterine contractions, intra uterine infection, or wornen having a maternal disease (hypertension, HELLP syndrome, preeclampsia or other) as reason for delivery. Placental or major structural fetal anomalies. Signs of cervical incompetence. Women whose child has signs of fetal distress (abnormal biophysical profile).

Outcomes

Primary Outcomes

Not specified

Similar Trials